Chordia Therapeutics Posts 1.47 Billion Yen Parent Operating Loss for 2025/26
Chordia Therapeutics reported a parent operating loss of 1.47 billion yen for 2025/26, versus a loss of 1.79 billion yen.
Chordia Therapeutics reported a parent operating loss of 1.47 billion yen for 2025/26, versus a loss of 1.79 billion yen.